165 related articles for article (PubMed ID: 16007223)
21. Akt phosphorylation regulates the tumour-suppressor merlin through ubiquitination and degradation.
Tang X; Jang SW; Wang X; Liu Z; Bahr SM; Sun SY; Brat D; Gutmann DH; Ye K
Nat Cell Biol; 2007 Oct; 9(10):1199-207. PubMed ID: 17891137
[TBL] [Abstract][Full Text] [Related]
22. Vibrational Stark effect spectroscopy at the interface of Ras and Rap1A bound to the Ras binding domain of RalGDS reveals an electrostatic mechanism for protein-protein interaction.
Stafford AJ; Ensign DL; Webb LJ
J Phys Chem B; 2010 Nov; 114(46):15331-44. PubMed ID: 20964430
[TBL] [Abstract][Full Text] [Related]
23. Biochemical and biological analyses of Rgr RalGEF oncogene.
Martello LA; Pellicer A
Methods Enzymol; 2006; 407():115-28. PubMed ID: 16757319
[TBL] [Abstract][Full Text] [Related]
24. Re-expression of the tumor suppressor NF2/merlin inhibits invasiveness in mesothelioma cells and negatively regulates FAK.
Poulikakos PI; Xiao GH; Gallagher R; Jablonski S; Jhanwar SC; Testa JR
Oncogene; 2006 Sep; 25(44):5960-8. PubMed ID: 16652148
[TBL] [Abstract][Full Text] [Related]
25. Identification and characterization of putative tumor suppressor NGB, a GTP-binding protein that interacts with the neurofibromatosis 2 protein.
Lee H; Kim D; Dan HC; Wu EL; Gritsko TM; Cao C; Nicosia SV; Golemis EA; Liu W; Coppola D; Brem SS; Testa JR; Cheng JQ
Mol Cell Biol; 2007 Mar; 27(6):2103-19. PubMed ID: 17210637
[TBL] [Abstract][Full Text] [Related]
26. Shedding light on Merlin's wizardry.
Okada T; You L; Giancotti FG
Trends Cell Biol; 2007 May; 17(5):222-9. PubMed ID: 17442573
[TBL] [Abstract][Full Text] [Related]
27. RILP suppresses invasion of breast cancer cells by modulating the activity of RalA through interaction with RalGDS.
Wang Z; Zhou Y; Hu X; Chen W; Lin X; Sun L; Xu X; Hong W; Wang T
Cell Death Dis; 2015 Oct; 6(10):e1923. PubMed ID: 26469971
[TBL] [Abstract][Full Text] [Related]
28. Double-mutant analysis of the interaction of Ras with the Ras-binding domain of RGL.
Shirouzu M; Hashimoto K; Kikuchi A; Yokoyama S
Biochemistry; 1999 Apr; 38(16):5103-10. PubMed ID: 10213614
[TBL] [Abstract][Full Text] [Related]
29. Merlin regulates transmembrane receptor accumulation and signaling at the plasma membrane in primary mouse Schwann cells and in human schwannomas.
Lallemand D; Manent J; Couvelard A; Watilliaux A; Siena M; Chareyre F; Lampin A; Niwa-Kawakita M; Kalamarides M; Giovannini M
Oncogene; 2009 Feb; 28(6):854-65. PubMed ID: 19029950
[TBL] [Abstract][Full Text] [Related]
30. Crystallization and preliminary crystallographic analysis of the Ras binding domain of RalGDS, a guanine nucleotide dissociation stimulator of the Ral protein.
Huang L; Jancarik J; Kim SH; Hofer F; Martin GS
Acta Crystallogr D Biol Crystallogr; 1996 Sep; 52(Pt 5):1033-5. PubMed ID: 15299618
[TBL] [Abstract][Full Text] [Related]
31. Neurofibromatosis 2 tumor suppressor protein, merlin, forms two functionally important intramolecular associations.
Gutmann DH; Haipek CA; Hoang Lu K
J Neurosci Res; 1999 Dec; 58(5):706-16. PubMed ID: 10561699
[TBL] [Abstract][Full Text] [Related]
32. Contact-dependent inhibition of EGFR signaling by Nf2/Merlin.
Curto M; Cole BK; Lallemand D; Liu CH; McClatchey AI
J Cell Biol; 2007 Jun; 177(5):893-903. PubMed ID: 17548515
[TBL] [Abstract][Full Text] [Related]
33. Serine 518 phosphorylation modulates merlin intramolecular association and binding to critical effectors important for NF2 growth suppression.
Rong R; Surace EI; Haipek CA; Gutmann DH; Ye K
Oncogene; 2004 Nov; 23(52):8447-54. PubMed ID: 15378014
[TBL] [Abstract][Full Text] [Related]
34. Functional analysis of the relationship between the neurofibromatosis 2 tumor suppressor and its binding partner, hepatocyte growth factor-regulated tyrosine kinase substrate.
Sun CX; Haipek C; Scoles DR; Pulst SM; Giovannini M; Komada M; Gutmann DH
Hum Mol Genet; 2002 Dec; 11(25):3167-78. PubMed ID: 12444101
[TBL] [Abstract][Full Text] [Related]
35. NF2: the wizardry of merlin.
Xiao GH; Chernoff J; Testa JR
Genes Chromosomes Cancer; 2003 Dec; 38(4):389-99. PubMed ID: 14566860
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the NF2 protein merlin and the ERM protein ezrin in human, rat, and mouse central nervous system.
Grönholm M; Teesalu T; Tyynelä J; Piltti K; Böhling T; Wartiovaara K; Vaheri A; Carpén O
Mol Cell Neurosci; 2005 Apr; 28(4):683-93. PubMed ID: 15797715
[TBL] [Abstract][Full Text] [Related]
37. Merlin, a tumor suppressor, interacts with transactivation-responsive RNA-binding protein and inhibits its oncogenic activity.
Lee JY; Kim H; Ryu CH; Kim JY; Choi BH; Lim Y; Huh PW; Kim YH; Lee KH; Jun TY; Rha HK; Kang JK; Choi CR
J Biol Chem; 2004 Jul; 279(29):30265-73. PubMed ID: 15123692
[TBL] [Abstract][Full Text] [Related]
38. Effects of Nf2 missense mutations on schwannomin interactions.
Scoles DR; Chen M; Pulst SM
Biochem Biophys Res Commun; 2002 Jan; 290(1):366-74. PubMed ID: 11779178
[TBL] [Abstract][Full Text] [Related]
39. RalGDS comes of age.
Rodriguez-Viciana P; McCormick F
Cancer Cell; 2005 Mar; 7(3):205-6. PubMed ID: 15766656
[TBL] [Abstract][Full Text] [Related]
40. Protein kinase A-mediated phosphorylation of the NF2 tumor suppressor protein merlin at serine 10 affects the actin cytoskeleton.
Laulajainen M; Muranen T; Carpén O; Grönholm M
Oncogene; 2008 May; 27(23):3233-43. PubMed ID: 18071304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
